← Leaderboards
Carol A. Mathews
Massachusetts General Hospital
$10,182,403
Attributed
$21,271,509
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,271,509 · 10
By mechanism
R01$18,352,217 · 6
R25$1,054,202 · 1
R61$822,159 · 1
K23$608,201 · 1
R21$434,730 · 1
Top collaborators
- Jeremiah M Scharf18 shared
- Robert Scott Mackin9 shared
- Peristera Paschou5 shared
- Victor I. Reus4 shared
- Chengguo Xing3 shared
- Andreas Keil2 shared
- Roel A Ophoff2 shared
- Jae Hoon Sul2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Oksana Berezovska$14,319,485
- Dora M Kovacs$12,707,695
- Jeremiah M Scharf$8,914,691
- Dorene May Rentz$5,307,321
- Merit E Cudkowicz$97,012,119
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectComorbidityPhenotypeFamilyComplexSamplingResearch PersonnelGeneticHeritabilitySymptomsFunctional DisabilitySeveritiesEtiologyLeadAttention Deficit Hyperactivity DisorderAdultFutureBaseInterviewMental DisordersGenetic ArchitectureParticipantDiagnosisGenetic Risk
Grant awards (46)
Visual perception and attention in the obsessive-compulsive/anxiety spectrum: Neurophysiological characterization, predictive value, and computational modeling$644,708
R01 · FY2025 · MH · contact PI
Visual perception and attention in the obsessive-compulsive/anxiety spectrum: Neurophysiological characterization, predictive value, and computational modeling$684,381
R01 · FY2024 · MH · contact PI
Large-Scale Collaborative Genetic and Epigenetic Studies of Tourette Syndrome$569,258
R01 · FY2023 · NS
Integrating Common and Rare Variation to Discover Genes Associated with Tourette Syndrome$956,462
R01 · FY2022 · NS
Large-scale collaborative genetic and epigenetic studies of Tourette Syndrome$572,743
R01 · FY2022 · NS
Hoarding disorder in older adults: cognition, etiology and functional impact$538,055
R01 · FY2022 · MH · contact PI
Hoarding disorder in older adults: cognition, etiology and functional impact$68,366
R01 · FY2022 · MH · contact PI
Integrating Common and Rare Variation to Discover Genes Associated with Tourette Syndrome$1,690,341
R01 · FY2021 · NS
Large-scale collaborative genetic and epigenetic studies of Tourette Syndrome$648,187
R01 · FY2021 · NS
Hoarding disorder in older adults: cognition, etiology and functional impact$586,936
R01 · FY2021 · MH · contact PI
Hoarding disorder in older adults: cognition, etiology and functional impact$136,724
R01 · FY2021 · MH · contact PI
Predicting populations at-risk of developing pathological hoarding$68,363
R01 · FY2021 · MH · contact PI
Integrating Common and Rare Variation to Discover Genes Associated with Tourette Syndrome$1,569,936
R01 · FY2020 · NS
Hoarding disorder in older adults: cognition, etiology and functional impact$597,529
R01 · FY2020 · MH · contact PI
Large-scale collaborative genetic and epigenetic studies of Tourette Syndrome$583,203
R01 · FY2020 · NS
Assessing blood biomarkers of dementia and neurodegeneration in early and late onset hoarding disorder$424,910
R01 · FY2020 · MH · contact PI
A phased clinical trial of a dietary supplement kava: biomarker changes and anxiolytic effects$375,597
R61 · FY2020 · AT
Admin Supp for A phased clinical trial of a dietary supplement kava: biomarker changes and anxiolytic effects$68,221
R61 · FY2020 · AT
Integrating Common and Rare Variation to Discover Genes Associated with Tourette Syndrome$1,436,594
R01 · FY2019 · NS
Large-scale collaborative genetic and epigenetic studies of Tourette Syndrome$751,865
R01 · FY2019 · NS
Hoarding disorder in older adults: cognition, etiology and functional impact$610,522
R01 · FY2019 · MH · contact PI
A phased clinical trial of a dietary supplement kava: biomarker changes and anxiolytic effects$378,341
R61 · FY2019 · AT
Integrating Common and Rare Variation to Discover Genes Associated with Tourette Syndrome$1,783,370
R01 · FY2018 · NS
Hoarding disorder in older adults: cognition, etiology and functional impact$676,632
R01 · FY2018 · MH · contact PI
Refining the Tourette Syndrome phenotype across diagnoses to aid gene discovery$322,000
R01 · FY2015 · MH · contact PI
Refining the Tourette Syndrome phenotype across diagnoses to aid gene discovery$83,289
R01 · FY2015 · MH · contact PI
Refining the Tourette Syndrome phenotype across diagnoses to aid gene discovery$413,188
R01 · FY2014 · MH · contact PI
Training the Next Generation of Mental Health Researchers$263,215
R25 · FY2014 · MH · contact PI
Refining the Tourette Syndrome phenotype across diagnoses to aid gene discovery$417,271
R01 · FY2013 · MH · contact PI
Training the Next Generation of Mental Health Researchers$254,087
R25 · FY2013 · MH · contact PI
Training the Next Generation of Mental Health Researchers$266,900
R25 · FY2012 · MH · contact PI
Training the Next Generation of Mental Health Researchers$270,000
R25 · FY2011 · MH · contact PI
Identifying Intermediate Phenotypes for Compulsive Hoarding$190,737
R21 · FY2011 · MH · contact PI
Identifying Intermediate Phenotypes for Compulsive Hoarding$243,993
R21 · FY2010 · MH · contact PI
An Affected SibPair Study of ADHD in Costa Rica$294,460
R01 · FY2009 · NS · contact PI
An Affected SibPair Study of ADHD in Costa Rica$285,884
R01 · FY2008 · NS · contact PI
An Affected SibPair Study of ADHD in Costa Rica$285,873
R01 · FY2007 · NS · contact PI
An Affected SibPair Study of ADHD in Costa Rica$285,546
R01 · FY2006 · NS · contact PI
An Affected SibPair Study of ADHD in Costa Rica$77,476
R01 · FY2006 · NS · contact PI
An Affected SibPair Study of ADHD in Costa Rica$288,145
R01 · FY2005 · NS
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$121,519
K23 · FY2004 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$121,694
K23 · FY2003 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$121,705
K23 · FY2002 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$91,460
K23 · FY2001 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$30,297
K23 · FY2001 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$121,526
K23 · FY2000 · RR